company background image
CREO

Creo Medical AIM:CREO Stock Report

Last Price

UK£0.54

Market Cap

UK£96.2m

7D

-12.2%

1Y

-68.5%

Updated

02 Oct, 2022

Data

Company Financials +
CREO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

CREO Stock Overview

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom.

Creo Medical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Creo Medical
Historical stock prices
Current Share PriceUK£0.54
52 Week HighUK£1.79
52 Week LowUK£0.53
Beta1.1
1 Month Change-21.17%
3 Month Change-41.30%
1 Year Change-68.51%
3 Year Change-65.05%
5 Year Change-34.54%
Change since IPO-32.50%

Recent News & Updates

Shareholder Returns

CREOGB Medical EquipmentGB Market
7D-12.2%1.3%-1.8%
1Y-68.5%-20.0%-15.2%

Return vs Industry: CREO underperformed the UK Medical Equipment industry which returned -20% over the past year.

Return vs Market: CREO underperformed the UK Market which returned -15.1% over the past year.

Price Volatility

Is CREO's price volatile compared to industry and market?
CREO volatility
CREO Average Weekly Movement3.7%
Medical Equipment Industry Average Movement5.8%
Market Average Movement5.5%
10% most volatile stocks in GB Market10.9%
10% least volatile stocks in GB Market2.9%

Stable Share Price: CREO is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CREO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003290Craig Gullifordhttps://creomedical.com

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues.

Creo Medical Limited Fundamentals Summary

How do Creo Medical's earnings and revenue compare to its market cap?
CREO fundamental statistics
Market CapUK£96.17m
Earnings (TTM)-UK£24.59m
Revenue (TTM)UK£25.16m

3.8x

P/S Ratio

-3.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CREO income statement (TTM)
RevenueUK£25.16m
Cost of RevenueUK£13.58m
Gross ProfitUK£11.59m
Other ExpensesUK£36.18m
Earnings-UK£24.59m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.14
Gross Margin46.04%
Net Profit Margin-97.75%
Debt/Equity Ratio11.6%

How did CREO perform over the long term?

See historical performance and comparison